Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 11/20 | 0.68 |
| ▸ | CDK2 | P24941 | 10/20 | 0.66 |
| ▸ | CCNE1 | P24864 | 6/20 | 0.66 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.55 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.55 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13998466 | 0.89 | CDK2 (0.69) | GSK3BCDK2CCNE1CHEK1CCNA2 | |
| SCHEMBL13998487 | 0.86 | GSK3B (0.52) | GSK3BCDK2CCNE1 | |
| SCHEMBL13998463 | 0.85 | GSK3B (0.52) | GSK3BCDK2CCNE1 | |
| SCHEMBL13998494 | 0.84 | GSK3B (0.71) | GSK3BCDK2CCNE1 | |
| SCHEMBL13998528 | 0.84 | GSK3B (0.62) | GSK3BCDK2CCNE1 | |
| SCHEMBL13998461 | 0.84 | GSK3B (0.82) | GSK3BCDK2CCNE1CCNA2CCNA1 | |
| SCHEMBL13998518 | 0.83 | MAPT (0.55) | GSK3BCDK2CCNE1 | |
| SCHEMBL13998499 | 0.83 | GSK3B (0.71) | GSK3BCDK2CCNE1 | |
| SCHEMBL13998516 | 0.83 | GSK3B (0.57) | GSK3BCDK2CCNE1 | |
| SCHEMBL13998500 | 0.83 | AHR (0.50) | GSK3BCDK2CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7470695-B2 | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2008-12-30 | — | — | US | disclosed |
| US-7470695-B2 | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2008-12-30 | — | — | US | disclosed |
| EP-1534709-B1 | PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORP (US) | 2007-06-13 | — | — | EP | disclosed |
| WO-2007044401-A2 | NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORPORATION (US) | 2007-04-19 | — | — | WO | disclosed |
| US-7196092-B2 | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2007-03-27 | — | — | US | disclosed |
| US-7196092-B2 | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2007-03-27 | — | — | US | disclosed |